SOLUSLABS LTD

Company Registration Number:
15281338 (England and Wales)

Unaudited statutory accounts for the year ended 30 November 2024

(Dormant)

Period of accounts

Start date: 13 November 2023

End date: 30 November 2024

SOLUSLABS LTD

Contents of the Financial Statements

for the Period Ended 30 November 2024

Company Information - 3
Balance sheet - 4
Additional notes - 6

SOLUSLABS LTD

Company Information

for the Period Ended 30 November 2024




Director: FURKAN AKMAN
Registered office: 71-75
Shelton Street
Covent Garden
London
GBR
WC2H 9JQ
Company Registration Number: 15281338 (England and Wales)

SOLUSLABS LTD

Balance sheet

As at 30 November 2024


Notes
13 months to
30 Nov 2024
£
Fixed assets
Total fixed assets: -
Current assets
Cash at bank and in hand: 127
Total current assets: 127
Net current assets (liabilities): 127
Total assets less current liabilities: 127
Total net assets (liabilities): 127

The notes form part of these financial statements

SOLUSLABS LTD

Balance sheet continued

As at 30 November 2024


Notes
13 months to
30 Nov 2024
£
Capital and reserves
Called up share capital: 127
Shareholders funds: 127

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

For the year ending 30 November 2024 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.

This report was approved by the board of directors on 26 January 2025
And Signed On Behalf Of The Board By:

Name: FURKAN AKMAN
Status: Director

The notes form part of these financial statements

SOLUSLABS LTD

Notes to the Financial Statements

for the Period Ended 30 November 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

SOLUSLABS LTD

Notes to the Financial Statements

for the Period Ended 30 November 2024

  • 2. Employees

    13 months to
    30 Nov 2024
    Average number of employees during the period 3

SOLUSLABS LTD

Notes to the Financial Statements

for the Period Ended 30 November 2024

  • 3. Off balance sheet disclosure

    No